2-methyl-2-phenylsuccinimide structure
|
Common Name | 2-methyl-2-phenylsuccinimide | ||
|---|---|---|---|---|
| CAS Number | 1497-17-2 | Molecular Weight | 189.21100 | |
| Density | 1.179g/cm3 | Boiling Point | 371.1ºC at 760mmHg | |
| Molecular Formula | C11H11NO2 | Melting Point | 83-85ºC(lit.) | |
| MSDS | Chinese USA | Flash Point | 165.3ºC | |
| Name | α-METHYL-α-PHENYLSUCCINIMIDE |
|---|---|
| Synonym | More Synonyms |
| Density | 1.179g/cm3 |
|---|---|
| Boiling Point | 371.1ºC at 760mmHg |
| Melting Point | 83-85ºC(lit.) |
| Molecular Formula | C11H11NO2 |
| Molecular Weight | 189.21100 |
| Flash Point | 165.3ºC |
| Exact Mass | 189.07900 |
| PSA | 46.17000 |
| LogP | 1.31960 |
| Vapour Pressure | 1.06E-05mmHg at 25°C |
| Index of Refraction | 1.55 |
| InChIKey | UDESUGJZUFALAM-UHFFFAOYSA-N |
| SMILES | CC1(c2ccccc2)CC(=O)NC1=O |
| RIDADR | NONH for all modes of transport |
|---|---|
| WGK Germany | 3 |
| HS Code | 2925190090 |
| Precursor 1 | |
|---|---|
| DownStream 1 | |
| HS Code | 2925190090 |
|---|---|
| Summary | 2925190090 other imides and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
|
Anticonvulsants Based on the α-Substituted Amide Group Pharmacophore Bind to and Inhibit Function of Neuronal Nicotinic Acetylcholine Receptors.
ACS Chem. Neurosci. 7 , 316-26, (2016) Although the antiepileptic properties of α-substituted lactams, acetamides, and cyclic imides have been known for over 60 years, the mechanism by which they act remains unclear. I report here that the... |
|
|
Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction.
Br. J. Pharmacol. 100(4) , 800-6, (1990) 1. Succinimide derivatives can be either convulsant (tetramethylsuccinimide (TMS)), or anticonvulsant (ethosuximide (ES); alpha-methyl-alpha-phenylsuccinimide (MPS)). ES, an anticonvulsant succinimide... |
|
|
Block of cloned human T-type calcium channels by succinimide antiepileptic drugs.
Mol. Pharmacol. 60(5) , 1121-32, (2001) Inhibition of T-type Ca(2+) channels has been proposed to play a role in the therapeutic action of succinimide antiepileptic drugs. Despite the widespread acceptance of this hypothesis, recent studies... |
| 3-Phenyl-3-methylpyrrolidine-2,5-dione |
| 3-Methyl-3-phenyl-pyrrolidin-2,5-dion |
| n-desmethylmethsuximide |
| A-METHYL-A-PHENYLSUCCINIMIDE |
| Mesuximide,M(nor-) |
| EINECS 216-091-7 |
| 3-Methyl-3-phenyl-2,5-pyrrolidinedione |
| MFCD00005496 |
| 3-methyl-3-phenylpyrrolidine-2,5-dione |
| Normesuximide |
| N-Demethylmethsuximide |
| 2-methyl-2-phenylsuccinimide |
| 3-phenyl-3-methyl succinic imide |
| (3RS)-3-Methyl-3-phenylsuccinimid |